Meet with us in Boston for World CB & CDx.
We’re thrilled to be a Spotlight Partner for the 14th World Clinical Biomarkers and Companion Diagnostics Summit. Join us there to exchange insights with biotech and pharma leaders, researchers, and scientists and to discuss the latest developments and innovations in biomarkers and companion diagnostics, including precision oncology, the integration of artificial intelligence and digital pathology, regulatory frameworks, and innovations to improve patient outcomes.
Since 2009, we’ve led the way in spatial biology, being among the first to utilize machine learning and AI for spatial analysis and establishing ourselves as the most dependable partner for your clinical program. With seventeen US patents backing our proprietary image analysis technology, Flagship partners with you to deliver customized data to meet your unique needs. Starting with assessment and determining the correct modalities, our dedicated and collaborative scientific and project management teams provide end-to-end support throughout the entire process, from pre-IND to commercialization.
- AI-powered digital pathology solutions
- Biomarker development and validation
- Spatial biology and molecular diagnostics analysis
- Clinical trial support
- CDx development
- Regulatory guidance
Interested in partnering with us? Meet with us to discuss how our spatial biology solutions can accelerate your research or drug development program.
Tom Turi, Ph.D.
Chief Scientific Officer at Flagship Biosciences
Thursday, September 5
12:50 PM ET
Spatial Biology to Enhance Targeted Therapeutics
- Evolution of Precision Medicine
- New approaches for biomarker discovery through spatial biology
- Applying spatial biology to support ADC development
Gene Expression Analysis Within Spatial Context
- Ability to rapidly translate your basic science discoveries into actionable clinical insights using state-of-the-art sequencing platforms from NanoString
- Combination of standard immunofluorescence techniques with digital optical barcoding technology to perform spatial, highly multiplexed, tissue profiling
- Wide range of standard and customizable gene expression panels
Tailored Companion Diagnostics solutions to meet your research needs
- Valuable insights that can inform clinical decisions and support drug development programs
- Expertise in developing assays for oncology, immune-oncology, neuromuscular disorders, and cell & gene therapies for rare diseases
- Preliminary research, tissue biomarker assay optimization, and assay validation
Validated Assays for Clinical Research & Drug Development
- Customizable options optimized to your needs and validation requirements
- Ability to create multiplex assays to characterize complex cellular interactions
Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications
- Expertise in novel biomarker and tissue analyses
- Regulatory strategy and support
- Consult with scientific experts